OSGIN1 and hepatocellular carcinoma: Liu et al. (2014) also found general downregulation of Osgin1 in hepatocellular carcinomas, with a reduction of 24.7% in comparison with surrounding healthy tissue, and this was correlated to lower survival times of the donor patients [52].